Covaxin Trial On 2-18 Year Olds "Amounts To Homicide": Plea In Delhi High Court
NDTV
The application was moved in a petition filed in May to set aside the permission granted by the country's drug regulator to Bharat Biotech for conducting vaccine trials on children.
A plea has been moved in the Delhi High Court seeking stay on the phase II/III clinical trials of Covaxin - Bharat Biotech's Covid Vaccine - on 2-18 year olds. The application was moved in a petition filed in May for setting aside the permission granted by the country's drug regulator - Drugs Controller General of India (DCGI) - to Bharat Biotech for conducting trials of its vaccine on children. Petitioner Sanjeev Kumar has claimed in his application that while the issue was pending before the High Court with notices issued to the Centre and Bharat Biotech, the trials have already commenced from June. He has said, in his plea, that since the court did not grant a stay when it heard the matter, the government is going ahead with the trials.More Related News